Safety and Tolerability of Odanacatib (0822-059)
Clinical trial NCT01068262 · COMPLETED
Trial details
- NCT number
- NCT01068262
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-08
- Primary completion
- 2010-04-26
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.